Neuraminidase Inhibitor
51 drugs across 17 manufacturers|46 Generic,5 Brand
The Neuraminidase Inhibitor class contains 51 NDCs from 17 manufacturers (46 generic, 5 brand), at an average NADAC of $1.46 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
51
46G / 5B
Manufacturers
17
Avg $1.4552/unit
Avg 7d Change
-0.54%
Across 44 drugs with changes
7d Activity
of 51 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
17 manufacturers producing drugs in this therapeutic class(6 pricing outliers)
and 5 more manufacturers
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Amneal Pharmaceuticals NY LLC manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
oseltamivir phosphate market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Neuraminidase Inhibitor class?
The Neuraminidase Inhibitor class contains 51 NDCs from 17 manufacturers — 46 generic and 5 brand products.
What is the average price of Neuraminidase Inhibitor drugs?
The average NADAC for the Neuraminidase Inhibitor class is $1.4552 per unit across 51 NDCs.
Is generic cheaper than brand in the Neuraminidase Inhibitor class?
Among products priced per EA, the average generic NADAC in this class is $0.7556, versus $11.0725 for brand — brand products average about 15× the generic price.
Which manufacturers make Neuraminidase Inhibitor drugs?
17 manufacturers make drugs in the Neuraminidase Inhibitor class. Ranked by number of NDCs, the largest are Amneal Pharmaceuticals NY LLC (7), Genentech, Inc. (4), Lannett Company Inc. (4), Alvogen Inc. (4), Strides Pharma Inc. (4).
How has Neuraminidase Inhibitor pricing changed recently?
Over the past 7 days, 11 NDCs in this class rose and 33 fell, with a class-wide average change of -0.5%.